| BOD1L1 |
biorientation of chromosomes in cell division 1 like 1 |
|
|
|
| CLNK |
cytokine dependent hematopoietic cell linker |
|
|
|
| GABBR1 |
gamma-aminobutyric acid type B receptor subunit 1 |
- Activation of G protein gated Potassium channels
- G alpha (i) signalling events
- Class C/3 (Metabotropic glutamate/pheromone receptors)
- GABA B receptor activation
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
|
- Baclofen
- Progabide
- Gabapentin
- Vigabatrin
- Taurine
- gamma-Aminobutyric acid
- SGS-742
- Arbaclofen
- Arbaclofen Placarbil
|
|
| HTRA3 |
HtrA serine peptidase 3 |
|
|
|
| JAK1 |
Janus kinase 1 |
- Interleukin-6 signaling
- Interleukin-6 signaling
- MAPK3 (ERK1) activation
- MAPK1 (ERK2) activation
- ISG15 antiviral mechanism
- Interleukin-7 signaling
- Interleukin-7 signaling
- Other interleukin signaling
- RAF/MAP kinase cascade
- Interleukin-10 signaling
- Interleukin-4 and Interleukin-13 signaling
- IL-6-type cytokine receptor ligand interactions
- Interferon gamma signaling
- Regulation of IFNG signaling
- Regulation of IFNG signaling
- Interleukin-20 family signaling
- Interleukin-15 signaling
- Interleukin-15 signaling
- Interleukin-35 Signalling
- Interleukin-9 signaling
- Interleukin-2 signaling
- Interleukin-12 signaling
- Interleukin-12 signaling
- Interleukin-27 signaling
- Interleukin-27 signaling
- Interleukin-21 signaling
- Interferon alpha/beta signaling
- Interleukin receptor SHC signaling
- Regulation of IFNA signaling
- Regulation of IFNA signaling
|
- Myricetin
- 2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE
- Ruxolitinib
- Tofacitinib
- Baricitinib
|
|
| MKX |
mohawk homeobox |
|
|
|
| MRFAP1L1 |
Morf4 family associated protein 1 like 1 |
|
|
|
| NKX2-1 |
NK2 homeobox 1 |
|
|
- Choreoathetosis, hypothyroidism, and neonatal respiratory distress
|
| TADA2B |
transcriptional adaptor 2B |
- HATs acetylate histones
- Ub-specific processing proteases
|
|
|
| TRMT44 |
tRNA methyltransferase 44 homolog |
- tRNA modification in the nucleus and cytosol
|
|
|
| TYK2 |
tyrosine kinase 2 |
- Interleukin-6 signaling
- Interleukin-6 signaling
- MAPK3 (ERK1) activation
- MAPK1 (ERK2) activation
- Other interleukin signaling
- Interleukin-10 signaling
- Interleukin-4 and Interleukin-13 signaling
- IL-6-type cytokine receptor ligand interactions
- Interleukin-20 family signaling
- Interleukin-35 Signalling
- Interleukin-12 signaling
- Interleukin-12 signaling
- Interleukin-23 signaling
- Interleukin-23 signaling
- Interleukin-27 signaling
- Interleukin-27 signaling
- Interferon alpha/beta signaling
- Regulation of IFNA signaling
- Regulation of IFNA signaling
|
- 2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE
- Tofacitinib
|
- Other well-defined immunodeficiency syndromes, including the following seven diseases: Wiskott-Aldrich syndrome; DiGeorge syndrome; Hyper-IgE syndrome; X-linked lymphoproliferative syndrome; Immunodeficiency, Polyendocrinopathy, Enteropathy, X-linked Syndrome (IPEX); Cartilage-Hair Hypoplasia; Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
|
| YWHAG |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma |
- Activation of BAD and translocation to mitochondria
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Regulation of PLK1 Activity at G2/M Transition
- Loss of Nlp from mitotic centrosomes
- Recruitment of mitotic centrosome proteins and complexes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Recruitment of NuMA to mitotic centrosomes
- Anchoring of the basal body to the plasma membrane
- RHO GTPases activate PKNs
- TP53 Regulates Metabolic Genes
- Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
- AURKA Activation by TPX2
- Regulation of localization of FOXO transcription factors
|
|
|